Javascript must be enabled to continue!
Proper chromosome alignment depends on BRCA2 phosphorylation by PLK1
View through CrossRef
Summary
The BRCA2 tumor suppressor protein is involved in the maintenance of genome integrity through its role in homologous recombination. In mitosis, BRCA2 is phosphorylated by Polo-like kinase 1 (PLK1). Here we describe how this phosphorylation contributes to the control of mitosis. We identified two highly conserved phosphorylation sites at S193 and T207 of BRCA2. Phosphorylated-T207 is a
bona fide
docking site for PLK1 as illustrated by the crystal structure of the BRCA2 peptide bound to PLK1 Polo-box domain. We found that BRCA2 bound to PLK1 forms a complex with the phosphatase PP2A and phosphorylated-BUBR1. Reducing BRCA2 binding to PLK1, as observed in
BRCA2
breast cancer variants S206C and T207A, alters the tetrameric complex resulting in misaligned chromosomes, faulty chromosome segregation and aneuploidy. We thus reveal a direct role of BRCA2 in the alignment of chromosomes, distinct from its DNA repair function, with important consequences on chromosome stability. These findings may explain in part the aneuploidy observed in
BRCA2
-mutated tumors.
Title: Proper chromosome alignment depends on BRCA2 phosphorylation by PLK1
Description:
Summary
The BRCA2 tumor suppressor protein is involved in the maintenance of genome integrity through its role in homologous recombination.
In mitosis, BRCA2 is phosphorylated by Polo-like kinase 1 (PLK1).
Here we describe how this phosphorylation contributes to the control of mitosis.
We identified two highly conserved phosphorylation sites at S193 and T207 of BRCA2.
Phosphorylated-T207 is a
bona fide
docking site for PLK1 as illustrated by the crystal structure of the BRCA2 peptide bound to PLK1 Polo-box domain.
We found that BRCA2 bound to PLK1 forms a complex with the phosphatase PP2A and phosphorylated-BUBR1.
Reducing BRCA2 binding to PLK1, as observed in
BRCA2
breast cancer variants S206C and T207A, alters the tetrameric complex resulting in misaligned chromosomes, faulty chromosome segregation and aneuploidy.
We thus reveal a direct role of BRCA2 in the alignment of chromosomes, distinct from its DNA repair function, with important consequences on chromosome stability.
These findings may explain in part the aneuploidy observed in
BRCA2
-mutated tumors.
Related Results
Proper chromosome alignment depends on BRCA2 phosphorylation by PLK1
Proper chromosome alignment depends on BRCA2 phosphorylation by PLK1
Abstract
The BRCA2 tumor suppressor protein is involved in the maintenance of genome integrity through its role in homologous recombination. ...
Breast Cancer Susceptibility Gene 2 Deficiency Exacerbates Angiotensin‐II‐induced Endothelial Dysfunction and Apoptosis
Breast Cancer Susceptibility Gene 2 Deficiency Exacerbates Angiotensin‐II‐induced Endothelial Dysfunction and Apoptosis
BackgroundGerm‐line mutations in the tumour suppressor genes BRCA1 and BRCA2 (BReast CAncer susceptibility genes 1 & 2) predispose carriers to breast cancer. BRCA1 and BRCA2 he...
Abstract B013: A quest for deeper understanding of BRCA2 Variants of Uncertain Significance (VUS)
Abstract B013: A quest for deeper understanding of BRCA2 Variants of Uncertain Significance (VUS)
Abstract
Deleterious mutations in homology-directed repair pathway genes impact both future cancer risk and therapeutic intervention options for cancer diagnosis and...
Abstract 1133: Plk1 phosphorylation of PTEN causes a tumor-promoting metabolic state
Abstract 1133: Plk1 phosphorylation of PTEN causes a tumor-promoting metabolic state
Abstract
One outcome of activation of the PI3K pathway is increased aerobic glycolysis, but the upstream signaling events that regulate the PI3K pathway, thus the Wa...
Abstract 3459: Dual targeting of BTK and PLK1 causes lethal synergistic effects in mantle cell lymphoma
Abstract 3459: Dual targeting of BTK and PLK1 causes lethal synergistic effects in mantle cell lymphoma
Abstract
Mantle cell lymphoma (MCL) is an incurable, aggressive B cell malignancy. Ibrutinib, an oral irreversible Bruton's tyrosine (BTK) inhibitor, was FDA-approve...
Abstract 1779: BRCA2 interacts with an essential replication factor, MCM10.
Abstract 1779: BRCA2 interacts with an essential replication factor, MCM10.
Abstract
The BRCA2 (Breast Cancer 2, early onset) gene is implicated in a variety of familial cancers. Loss of BRCA2 function results in severe defects in DNA double...
The interrelationship between APC/C and Plk1 activities in centriole disengagement
The interrelationship between APC/C and Plk1 activities in centriole disengagement
Summary
Mother–daughter centriole disengagement, the necessary first step in centriole duplication, involves Plk1 activity in early mitosis and separase activity aft...
Abstract OI-1: OI-1 Decoding breast cancer predisposition genes
Abstract OI-1: OI-1 Decoding breast cancer predisposition genes
Abstract
Women with one or more first-degree female relatives with a history of breast cancer have a two-fold increased risk of developing breast cancer. This risk i...

